Connection

Chadrick Denlinger to Proto-Oncogene Proteins p21(ras)

Back to Details
This is a "connection" page, showing publications Chadrick Denlinger has written about Proto-Oncogene Proteins p21(ras).
Chadrick Denlinger
Connection Strength
0.029
Proto-Oncogene Proteins p21(ras)
  1. Phase II study of selumetinib (AZD6244, ARRY-142886) plus irinotecan as second-line therapy in patients with K-RAS mutated colorectal cancer. Cancer Chemother Pharmacol. 2015 Jan; 75(1):17-23.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.